Cooperation between action medeor, Bayer, Boehringer Ingelheim and Merck enters second phase

To better protect patients from undesirable side effects of medicines, pharmacists will be more closely involved in Tanzanian clinics. This is the goal of a multi-stakeholder partnership (MSP) launched by action medeor, Bayer, Boehringer Ingelheim and Merck, which is now entering its second phase. In the first phase, a roundtable was initiated in 2017 for uniform and comprehensive training of pharmaceutical assistants and technicians, to ensure the care of patients in rural areas of Tanzania.

The press release of action medeor (in german) can be found here.

This might also interest you:

p2023 news thumbnail
● News
When External Funding Ends: An Example from the Sustainable Soy Alliance in Brazil
p2023 news thumbnail
● News
Partnerships2030 Peer Learning Format: Learning from each other
p2023 news thumbnail
● News
Partnering for Impact: Developing Skills Needed for Successful Cooperation in Transformative Partnerships